跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,732 条关于
“BA.4.6”
全部
1,732
临床试验
825
药物
262
机构
242
资讯
403
3年前
FDA Restricts Emergency Use Authorization for AstraZeneca's Evusheld in the US
去年
FDA Limits GSK's Xevudy Authorization Due to BA.2 Variant Concerns
去年
Beyond Air's NeuroNOS Receives FDA Orphan Drug Designation for Glioblastoma Therapy BA-101
去年
Vaxart Advances Oral Vaccine Programs for COVID-19, Norovirus, and Influenza
4年前
FDA Restricts Sotrovimab Use Due to Omicron BA.2 Variant Resistance
去年
FDA Revokes Authorization of GSK and Vir's Sotrovimab Due to BA.2 Inefficacy
去年
Pfizer and BioNTech Seek FDA Authorization for COVID-19 Vaccine in Young Children
9个月前
US FDA Updates Safety Reporting Guidelines for Bioavailability and Bioequivalence Studies, Indian Pharma Industry Responds Positively
5天前
India's DTAB Proposes Amendment to NDCT Rules to Add GMP Requirements for Trial Batches
去年
Bovhyaluronidase Azoximer Shows Promise in Treating Pulmonary Sequelae of COVID-19
第 1 页,共 41 页
上一页
下一页